Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alzheimer’s Disease and Epilepsy: A Perspective on the Opportunities for Overlapping Therapeutic Innovation
Leanne M Lehmann, Alexandria Lo, Kevin M. Knox, et al.
Neurochemical Research (2021) Vol. 46, Iss. 8, pp. 1895-1912
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Chronic evoked seizures in young pre-symptomatic APP/PS1 mice induce serotonin changes and accelerate onset of Alzheimer’s disease-related neuropathology
Aarón del Pozo, Kevin M. Knox, Leanne M Lehmann, et al.
Progress in Neurobiology (2024) Vol. 235, pp. 102591-102591
Open Access | Times Cited: 11
Interictal spikes in Alzheimer's disease: Preclinical evidence for dominance of the dentate gyrus and cholinergic control by the medial septum
Christos Panagiotis Lisgaras, Helen E. Scharfman
Neurobiology of Disease (2023) Vol. 187, pp. 106294-106294
Open Access | Times Cited: 17
The clinical correlation between Alzheimer's disease and epilepsy
Dandan Zhang, Siyuan Chen, Shoucheng Xu, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 27
Mechanisms Involved in Epileptogenesis in Alzheimer’s Disease and Their Therapeutic Implications
Miren Altuna, Gonzalo Olmedo‐Saura, María Carmona‐Iragui, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4307-4307
Open Access | Times Cited: 25
Empagliflozin Induced Ketosis, Upregulated IGF-1/Insulin Receptors and the Canonical Insulin Signaling Pathway in Neurons, and Decreased the Excitatory Neurotransmitter Glutamate in the Brain of Non-Diabetics
Konstantinos Avgerinos, Roger J. Mullins, Michael Vreones, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3372-3372
Open Access | Times Cited: 22
Neuroinflammation: A Common Pathway in Alzheimer’s Disease and Epilepsy
Yee Liew, Thaarvena Retinasamy, Alina Arulsamy, et al.
Journal of Alzheimer s Disease (2023) Vol. 94, Iss. s1, pp. S253-S265
Open Access | Times Cited: 14
Chronic seizures induce sex-specific cognitive deficits with loss of presenilin 2 function
Kevin M. Knox, Megan Beckman, Carole Smith, et al.
Experimental Neurology (2023) Vol. 361, pp. 114321-114321
Closed Access | Times Cited: 13
Under the umbrella of depression and Alzheimer’s disease physiopathology: Can cannabinoids be a dual-pleiotropic therapy?
Carla Fonseca, Miren Ettcheto, Joana Bicker, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 101998-101998
Open Access | Times Cited: 13
Alzheimer’s Disease and Epilepsy: Exploring Shared Pathways and Promising Biomarkers for Future Treatments
Athanasios-Christos Kalyvas, Maria Dimitriou, Panagiotis Ioannidis, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 13, pp. 3879-3879
Open Access | Times Cited: 5
Entorhinal cortex vulnerability to human APP expression promotes hyperexcitability and tau pathology
Annie M Goettemoeller, Emmie Banks, Prateek Kumar, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Seizing the opportunity to therapeutically address neuronal hyperexcitability in Alzheimer's disease
Melissa Barker‐Haliski
Journal of Alzheimer s Disease (2025)
Closed Access
High‐frequency oscillations (250–500 Hz) in animal models of Alzheimer's disease and two animal models of epilepsy
Christos Panagiotis Lisgaras, Helen E. Scharfman
Epilepsia (2022) Vol. 64, Iss. 1, pp. 231-246
Open Access | Times Cited: 21
Higher susceptibility to 6 Hz corneal kindling and lower responsiveness to antiseizure drugs in mouse models of Alzheimer's disease
Maxime Vande Vyver, Melissa Barker‐Haliski, Najat Aourz, et al.
Epilepsia (2022) Vol. 63, Iss. 10, pp. 2703-2715
Open Access | Times Cited: 19
The role of parvalbumin interneuron dysfunction across neurodegenerative dementias
Carmelo Smeralda, Siddhartha Pandit, Sonia Turrini, et al.
Ageing Research Reviews (2024), pp. 102509-102509
Closed Access | Times Cited: 4
Sleep: The Tip of the Iceberg in the Bidirectional Link Between Alzheimer's Disease and Epilepsy
Anna B. Szabo, Benjamin Cretin, Fleur Gérard, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 16
Antiseizure Medications in Alzheimer’s Disease from Preclinical to Clinical Evidence
Francesca Bosco, Lorenza Guarnieri, Vincenzo Rania, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12639-12639
Open Access | Times Cited: 9
Innovative drug discovery strategies in epilepsy: integrating next-generation syndrome-specific mouse models to address pharmacoresistance and epileptogenesis
Melissa Barker‐Haliski, Nicole A. Hawkins
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 9, pp. 1099-1113
Closed Access | Times Cited: 3
Loss of Extrasynaptic Inhibitory Glycine Receptors in the Hippocampus of an AD Mouse Model Is Restored by Treatment with Artesunate
Jochen Kuhse, Femke Groeneweg, Stefan Kins, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4623-4623
Open Access | Times Cited: 8
Focused Review: Clinico-Neuropathological Aspects of Late Onset Epilepsies
Áttila Rácz, Daniel S. Galvis-Montes, Valeri Borger, et al.
Seizure (2024)
Closed Access | Times Cited: 2
Somatostatin: Linking Cognition and Alzheimer Disease to Therapeutic Targeting
Karin E. Sandoval, K. Witt
Pharmacological Reviews (2024) Vol. 76, Iss. 6, pp. 1291-1325
Closed Access | Times Cited: 2
mRNA and circRNA mislocalization to synapses are key features of Alzheimer’s disease
Samuel N. Smukowski, Cassidy Danyko, Jenna Somberg, et al.
PLoS Genetics (2024) Vol. 20, Iss. 7, pp. e1011359-e1011359
Open Access | Times Cited: 2
Alzheimer’s disease and epilepsy: The top 100 cited papers
Guifen Zhang, Wen-Xin Gong, Zheng-Yan-Ran Xu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 12
Prevalence and localization of nocturnal epileptiform discharges in mild cognitive impairment
Rosario Ciliento, Klevest Gjini, Kevin Dabbs, et al.
Brain Communications (2023) Vol. 5, Iss. 6
Open Access | Times Cited: 6
Mechanisms Involved in Epileptogenesis in Alzheimer’s Disease and Their Therapeutic Implications
Miren Altuna, Gonzalo Olmedo, María Carmona‐Iragui, et al.
(2022)
Open Access | Times Cited: 10
Can Old Animals Reveal New Targets? The Aging and Degenerating Brain as a New Precision Medicine Opportunity for Epilepsy
Aarón del Pozo, Leanne M Lehmann, Kevin M. Knox, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top